A5017748711- Cardiac Valve Diseases and Treatments
- Aortic Disease and Treatment Approaches
- Infective Endocarditis Diagnosis and Management
- Machine Learning in Healthcare
- Heart Failure Treatment and Management
- Gut microbiota and health
- Clostridium difficile and Clostridium perfringens research
- Liver Disease Diagnosis and Treatment
- Sepsis Diagnosis and Treatment
Second Affiliated Hospital of Zhejiang University
2023-2024
Panyu District Central Hospital
2022
South China Normal University
2022
Abstract Background Predicting hospital mortality risk is essential for the care of heart failure patients, especially those in intensive units. Methods Using a novel machine learning algorithm, we constructed stratification tool that correlated patients’ clinical features and in-hospital mortality. We used extreme gradient boosting algorithm to generate model predicting patients unit derivation dataset 5676 from Medical Information Mart Intensive Care III database. The logistic regression...
The gut microbiome is associated with hepatitis B virus (HBV)-induced liver disease, which progresses from chronic B, to cirrhosis, and eventually hepatocellular carcinoma. Studies have analyzed the at each stage of HBV-induced diseases, but a consensus has not been reached on microbial signatures across these stages. Here, we conducted by systematic meta-analysis 486 fecal samples publicly available 16S rRNA gene datasets all disease stages, validated results characterization an independent...
Background: Comparative data of the Valve Academic Research Consortium (VARC-3)-defined technical success between bicuspid versus tricuspid aortic stenosis (AS) remain lacking. Aims: We sought to compare and other clinical outcomes patients with AS receiving transcatheter valve replacement. Methods: A registration-based analysis was performed for 402 (211 191 cases AS, respectively). The primary outcome VARC-3-defined success. Additional assess up one year two groups. Results: Bicuspid...